GORDON ROBINSON: Open Payments
NPI 1245342161 · ST. LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 11 payments from 7 companies in 2025. Trend: 2023 $441 · 2024 $647 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $135 |
| Corium, LLC | 2 | $49 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
Products named: COBENFY, Azstarys, Auvelity, Qelbree, CAPLYTA, REXULTI, ARISTADA.
Industry payments across MO — which companies pay providers there.
